doxazosin has been researched along with furosemide in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abildgaard, U; Christensen, S; Petersen, JS; Shalmi, M | 1 |
| Ebihara, A; Fujimura, A; Ohashi, K; Shiga, T; Sudoh, T | 1 |
| Beaman, M; D'Souza, RJ; Hamilton-Wood, C; Nicholls, AJ; Pearson, ER | 1 |
| Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA | 1 |
| Davenport, AP; Dhaun, N; Ferro, CJ; Goddard, J; Haynes, WG; Webb, DJ | 1 |
| Fang, RJ; Huang, SY; Zeng, BW; Zhu, DS; Zhu, SX | 1 |
| Alvarez-Ude, F; Fernández-Reyes, MJ; Heras, M; Pardo, J; Saiz, A; Sánchez, R | 1 |
| Arcas Bellas, JJ; López Pérez, V; Mesa Ruiz, JL; Tebar Cuesta, MY | 1 |
1 review(s) available for doxazosin and furosemide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for doxazosin and furosemide
| Article | Year |
|---|---|
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
Topics: Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Doxazosin; Enalapril; Endothelin Receptor Antagonists; Furosemide; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Peptides, Cyclic; Prospective Studies | 2007 |
[Frusemide plus doxazosin therapy for nocturia in patients with BPH/LUTS].
Topics: Aged; Aged, 80 and over; Doxazosin; Furosemide; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia | 2010 |
12 other study(ies) available for doxazosin and furosemide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Drug Interactions; Female; Furosemide; Infusions, Intravenous; Kidney Function Tests; Kidney Tubules, Proximal; Lithium; Prazosin; Rats; Rats, Inbred Strains; Sodium | 1991 |
Influence of alpha-receptor blockade on the time-dependent change in the effect of furosemide.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Doxazosin; Furosemide; Male; Rats; Rats, Wistar; Sodium; Time Factors | 1993 |
Hypertensive encephalopathy and nephrotic syndrome: a possible link?
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Azathioprine; Brain Diseases; Calcium Channel Blockers; Diuretics; Doxazosin; Female; Furosemide; Headache; Humans; Hypertension; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Nifedipine; Prednisolone; Seizures; Visual Acuity | 1999 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosin; Drug Therapy, Combination; Famotidine; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Male; Muscular Diseases; Mycophenolic Acid; Pneumonia, Bacterial; Postoperative Complications; Prednisone; Sirolimus | 2004 |
[Rapidly progressive renal failure as the onset of an IgA nephropathy in an elderly patient].
Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Biphenyl Compounds; Disease Progression; Diuretics; Doxazosin; Drug Therapy, Combination; Enalapril; Furosemide; Glomerulonephritis, IGA; Humans; Irbesartan; Male; Methylprednisolone; Nocturia; Prednisone; Prostatic Neoplasms; Remission Induction; Renal Dialysis; Tetrazoles | 2011 |
Management of hypertensive crisis with clevidipine in the perioperative setting of a critically ill patient, non-responder to high doses of nitroglycerin, labelatol, urapidil, doxazosin and furosemide.
Topics: Critical Illness; Doxazosin; Furosemide; Humans; Nitroglycerin; Piperazines; Pyridines | 2021 |